Close Menu

CHICAGO – A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19.

The fledgling EndPandemic National Data Consortium said last week that seven firms have signed on to the group within two weeks of its formation to work toward data-driven responses to SARS-CoV-2 and related COVID-19 disease. They plan on integrating and analyzing data from current and future clinical trials and clinical records to accelerate research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Sponsored by

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program.